Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia

Description

The purpose of the research project is to collect one blood sample from participants who are affected by very low platelets as a result of their condition or their treatment.

Conditions

Thrombocytopenia

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of the research project is to collect one blood sample from participants who are affected by very low platelets as a result of their condition or their treatment.

Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia

Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia

Condition
Thrombocytopenia
Intervention / Treatment

-

Contacts and Locations

Cleveland

Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland, Ohio, United States, 44195

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Adults 18 years or older
  • 2. Platelet counts of 30,000/mcl or less
  • 1. Chemotherapy within the last 24 hours from the planned blood sample draw for research purposes.
  • 2. Use of anticoagulant agents in the last 48 hours.
  • 3. Active infection (i.e. one that has received less than 48 hours of active treatment).
  • 4. Adults 89 years or older

Ages Eligible for Study

18 Years to 88 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Case Comprehensive Cancer Center,

Paolo Caimi, MD, PRINCIPAL_INVESTIGATOR, Case Comprehensive Cancer Center, Cleveland Clinic Taussig Cancer Institute

Study Record Dates

2025-12-31